MedTrace Logo

Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients

NCT00397358 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2025-03-03

No results posted yet for this study

Summary

This is a Phase IV study evaluating triglyceride levels in peritoneal dialysis patients.

Conditions

  • Peritoneal Dialysis
  • Hypertriglyceridemia

Interventions

DRUG

Extraneal (7.5% icodextrin) Peritoneal Dialysis Solution

Sponsors & Collaborators

  • Baxter Healthcare Corporation

    collaborator INDUSTRY

  • Vantive Health LLC

    lead INDUSTRY

Principal Investigators

  • Baxter Healthcare Corporation · Call central contact for information

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2007-06-30
Completion
2007-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00397358 on ClinicalTrials.gov